Related Experiment Video
Updated: Apr 8, 2026

Epigenetic Regulation of Cardiac Differentiation of Embryonic Stem Cells and Tissues
Published on: June 3, 2016
Histone deacetylases and cardiovascular cell lineage commitment
Jun-Yao Yang1, Qian Wang1, Wen Wang1
1Jun-Yao Yang, Qian Wang, Laboratory Medicine Centre, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China.
Insights
Histone deacetylases (HDACs) regulate genes involved in cardiovascular diseases. This review explores how HDACs and their inhibitors impact stem cell differentiation for potential cardiovascular therapies.
Area of Science:
- Cardiovascular biology
- Epigenetics
- Stem cell therapy
Background:
- Cardiovascular diseases (CVDs) are a leading global cause of death, linked to inflammation, lipid disorders, and endothelial dysfunction.
- Stem cell therapy is emerging as a promising treatment for CVDs, aiming to regenerate damaged heart and vascular tissues.
- Histone deacetylases (HDACs) are epigenetic regulators crucial for biological processes, including cardiovascular health, by influencing vascular cell homeostasis.
Purpose of the Study:
- To review the roles of various HDACs in cardiovascular diseases.
- To examine the impact of HDAC inhibitors on stem/progenitor cell differentiation into vascular lineages.
- To discuss the therapeutic potential of targeting HDACs in CVD treatment.
Main Methods:
- Literature review focusing on HDACs, stem cells, and cardiovascular disease.
- Analysis of studies investigating HDACs' function in endothelial cells, smooth muscle cells, and cardiomyocytes.
- Exploration of research on HDAC inhibitors' effects on stem cell differentiation.
Main Results:
- HDACs play critical roles in modulating vascular cell proliferation, migration, and apoptosis.
- HDACs influence stem and progenitor cell differentiation towards endothelial cells, smooth muscle cells, and cardiomyocytes.
- HDAC inhibitors show potential in directing stem cell differentiation for cardiovascular regeneration.
Conclusions:
- HDACs are significant epigenetic regulators in cardiovascular pathophysiology.
- Targeting HDACs offers a novel therapeutic strategy for CVDs by leveraging stem cell differentiation.
- Further research into HDAC inhibitors could unlock new avenues for regenerative cardiovascular medicine.
Abstract:
Cardiovascular diseases (CVDs), which include all diseases of the heart and circulation system, are the leading cause of deaths on the globally. During the development of CVDs, choric inflammatory, lipid metabolism disorder and endothelial dysfunction are widely recognized risk factors. Recently, the new treatment for CVDs that designed to regenerate the damaged myocardium and injured vascular endothelium and improve recovery by the use of stem cells, attracts more and more public attention. Histone deacetylases (HDACs) are a family of enzymes that remove acetyl groups from lysine residues of histone proteins allowing the histones to wrap the DNA more tightly and commonly known as epigenetic regulators of gene transcription. HDACs play indispensable roles in nearly all biological processes, such as transcriptional regulation, cell cycle progression and developmental events, and have originally shown to be involved in cancer and neurological diseases. HDACs are also found to play crucial roles in cardiovascular diseases by modulating vascular cell homeostasis (e.g., proliferation, migration, and apoptosis of both ECs and SMCs). This review focuses on the roles of different members of HDACs and HDAC inhibitor on stem cell/ progenitor cell differentiation toward vascular cell lineages (endothelial cells, smooth muscle cells and Cardiomyocytes) and its potential therapeutics.
More Related Videos
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
10:46Efficient Derivation of Human Cardiac Precursors and Cardiomyocytes from Pluripotent Human Embryonic Stem Cells with Small Molecule Induction
Published on: November 3, 2011
Related Concept Videos
Lineage Commitment
Chromatin Modification in iPS Cells
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Histone Modification
Inheritance of Chromatin Structures
Spreading of Chromatin Modifications
Writers
The writer...